Biophytis: Funding, Investors & Team (Sep 2026)
Biophytis is a biotechnology company in the clinical stage that is dedicated to developing treatments that can delay the aging process and enhance the quality of life for individuals with age-related diseases. Their objective is to become a pioneer in the field of aging science by providing groundbreaking therapies to address the unmet needs of a growing population of patients. To achieve this goal, they have brought together a team of experts and thought leaders in various fields from top industry and academic institutions worldwide.
Biophytis has raised $22.7M across 3 funding rounds on record, the most recent an undisclosed round of $8.9M announced in Jan 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Biophytis Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Biophytis Funding Rounds
Biophytis raised $11.3M in a Post-IPO Debt announced in Nov 2021.
1.5 years later, an undisclosed round of $2.5M was announced in May 2023.
1.7 years later, an undisclosed round of $8.9M was announced in Jan 2025.
Biophytis Founders and Leadership Team
Contact details for the Biophytis team: 1 of 1 has an email address on file.
Start 14-day free trial →Biophytis Funding Compared to Other Biotechnology Startups
Biophytis' latest round of $8.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Biophytis in Biotechnology and Paris
Companies Similar to Biophytis
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
Biophytis Funding FAQs
What does Biophytis do?
Biophytis is a biotechnology company in the clinical stage that is dedicated to developing treatments that can delay the aging process and enhance the quality of life for individuals with age-related diseases. Their objective is to become a pioneer in the field of aging science by providing groundbreaking therapies to address the unmet needs of a growing population of patients. To achieve this goal, they have brought together a team of experts and thought leaders in various fields from top industry and academic institutions worldwide.
How much funding has Biophytis raised?
Biophytis has raised $22.7M across 3 rounds on record. The most recent is an undisclosed round of $8.9M announced in Jan 2025.
When did Biophytis last raise funding?
Biophytis' most recent funding round on record is an undisclosed round of $8.9M, announced in Jan 2025.
Who is the CEO of Biophytis?
Stanislas Veillet is listed as CEO at Biophytis.
Where is Biophytis headquartered?
Biophytis is based in Paris, Ile-De-France, France.
How many employees does Biophytis have?
Biophytis is in the 11-50 employee band.
How does Biophytis' funding compare to other Biotechnology startups?
Biophytis' latest round of $8.9M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Biophytis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biophytis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.